144 related articles for article (PubMed ID: 21119539)
21. Transaldolase deficiency in two new patients with a relative mild phenotype.
Tylki-Szymańska A; Stradomska TJ; Wamelink MM; Salomons GS; Taybert J; Pawłowska J; Jakobs C
Mol Genet Metab; 2009 May; 97(1):15-7. PubMed ID: 19299175
[TBL] [Abstract][Full Text] [Related]
22. The unexplored potential of the pentose phosphate pathway in health and disease.
Berry GT
J Inherit Metab Dis; 2008 Dec; 31(6):661. PubMed ID: 19015949
[No Abstract] [Full Text] [Related]
23. Liver Disease and Risk of Hepatocellular Carcinoma in Children With Mutations in TALDO1.
Grammatikopoulos T; Hadzic N; Foskett P; Strautnieks S; Samyn M; Vara R; Dhawan A; Hertecant J; Al Jasmi F; Rahman O; Deheragoda M; Bull LN; Thompson RJ;
Hepatol Commun; 2022 Mar; 6(3):473-479. PubMed ID: 34677006
[TBL] [Abstract][Full Text] [Related]
24. The human transaldolase gene (TALDO1) is located on chromosome 11 at p15.4-p15.5.
Banki K; Eddy RL; Shows TB; Halladay DL; Bullrich F; Croce CM; Jurecic V; Baldini A; Perl A
Genomics; 1997 Oct; 45(1):233-8. PubMed ID: 9339383
[TBL] [Abstract][Full Text] [Related]
25. Modulation of talA gene in pentose phosphate pathway for overproduction of poly-beta-hydroxybutyrate in transformant Escherichia coli harboring phbCAB operon.
Song BG; Kim TK; Jung YM; Lee YH
J Biosci Bioeng; 2006 Sep; 102(3):237-40. PubMed ID: 17046540
[TBL] [Abstract][Full Text] [Related]
26. Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency.
Huck JH; Struys EA; Verhoeven NM; Jakobs C; van der Knaap MS
Clin Chem; 2003 Aug; 49(8):1375-80. PubMed ID: 12881455
[TBL] [Abstract][Full Text] [Related]
27. Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients.
Williams M; Valayannopoulos V; Altassan R; Chung WK; Heijboer AC; Keng WT; Lapatto R; McClean P; Mulder MF; Tylki-Szymańska A; Walenkamp ME; Alfadhel M; Alakeel H; Salomons GS; Eyaid W; Wamelink MMC
J Inherit Metab Dis; 2019 Jan; 42(1):147-158. PubMed ID: 30740741
[TBL] [Abstract][Full Text] [Related]
28. Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype.
Eyaid W; Al Harbi T; Anazi S; Wamelink MM; Jakobs C; Al Salammah M; Al Balwi M; Alfadhel M; Alkuraya FS
J Inherit Metab Dis; 2013 Nov; 36(6):997-1004. PubMed ID: 23315216
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of IRE1 modifies hypoxic regulation of G6PD, GPI, TKT, TALDO1, PGLS and RPIA genes expression in U87 glioma cells.
Minchenko OH; Garmash IA; Minchenko DO; Kuznetsova AY; Ratushna OO
Ukr Biochem J; 2017; 89(1):38-49. PubMed ID: 29236388
[TBL] [Abstract][Full Text] [Related]
30. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH) presenting with acute fulminant hepatic failure.
Mhanni AA; Chan A; Collison M; Seifert B; Lehotay DC; Sokoro A; Huynh HQ; Greenberg CR
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):312-5. PubMed ID: 18376250
[TBL] [Abstract][Full Text] [Related]
31. Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy.
Huck JH; Verhoeven NM; Struys EA; Salomons GS; Jakobs C; van der Knaap MS
Am J Hum Genet; 2004 Apr; 74(4):745-51. PubMed ID: 14988808
[TBL] [Abstract][Full Text] [Related]
32. Short-chain hydroxyacyl-coenzyme A dehydrogenase deficiency presenting as unexpected infant death: A family study.
Treacy EP; Lambert DM; Barnes R; Boriack RL; Vockley J; O'brien LK; Jones PM; Bennett MJ
J Pediatr; 2000 Aug; 137(2):257-9. PubMed ID: 10931422
[TBL] [Abstract][Full Text] [Related]
33. [Heterozygous NADH-methemoglobin reductase defect with methemoglobinemia in an infant (author's transl)].
Witt I; Gunkel J; Seibert G; Wehinger H; Schuchmann L; Künzer W
Z Kinderheilkd; 1973 Nov; 115(4):273-81. PubMed ID: 4149782
[No Abstract] [Full Text] [Related]
34. Alpha-1-antitrypsin deficiency and disease.
Alper CA; Johnson AM
Pediatrics; 1970 Dec; 46(6):837-40. PubMed ID: 4923511
[No Abstract] [Full Text] [Related]
35. Clinical and molecular characteristics of two transaldolase-deficient patients.
Tylki-Szymanska A; Wamelink MM; Stradomska TJ; Salomons GS; Taybert J; Dąbrowska-Leonik N; Rurarz M
Eur J Pediatr; 2014 Dec; 173(12):1679-82. PubMed ID: 24497183
[TBL] [Abstract][Full Text] [Related]
36. Lysine144 is essential for the catalytic activity of Saccharomyces cerevisiae transaldolase.
Miosga T; Schaaff-Gerstenschlager I; Franken E; Zimmermann FK
Yeast; 1993 Nov; 9(11):1241-9. PubMed ID: 8109173
[TBL] [Abstract][Full Text] [Related]
37. The pathogenesis of transaldolase deficiency.
Perl A
IUBMB Life; 2007 Jun; 59(6):365-73. PubMed ID: 17613166
[TBL] [Abstract][Full Text] [Related]
38. Detection of transaldolase deficiency by quantification of novel seven-carbon chain carbohydrate biomarkers in urine.
Wamelink MM; Smith DE; Jansen EE; Verhoeven NM; Struys EA; Jakobs C
J Inherit Metab Dis; 2007 Oct; 30(5):735-42. PubMed ID: 17603756
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.
Perl A; Hanczko R; Telarico T; Oaks Z; Landas S
Trends Mol Med; 2011 Jul; 17(7):395-403. PubMed ID: 21376665
[TBL] [Abstract][Full Text] [Related]
40. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.
Heinrich PC; Morris HP; Weber G
Cancer Res; 1976 Sep; 36(9 pt.1):3189-97. PubMed ID: 10080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
